Many runners have experienced what can happen when they are deep in training–perhaps performing at their peak–only to contract an upper respiratory infection or suffer a serious injury requiring ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

Hopwood [8] reported that among 23 pregnant patients who developed pneumonia, all had prior upper respiratory tract infection and 20 ... C drug -- but this agent has also not been adequately ...

As we brace ourselves for the winter months, it's wise to be prepared. With brands like Cepacol®, Panado®, Compral®, ...

AT-II-receptor antagonists were developed as agents that would more completely ... receptor antagonists dizziness, headache, upper-respiratory- tract infection, cough, and gastrointestinal ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...

Nipocalimab, an emerging therapeutic agent for hemolytic disease of the fetus and newborn (HDFN), does not appear to affect ...

For older adults in the Western US, exposure to smoke pollution is associated with an increase in hospitalizations for respiratory diseases.

Vaccines save millions of lives every year, but there is still an urgent need for more efficient vaccines. Strategies to combat serious outbreaks of viral infections are particularly important. Such ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the first quarter of 2025, along with recent ...